Melanoma
Melanoma
Advertisement
Jordana JampelMelanoma | November 18, 2024
Seventy-two percent of tumor specimens contained histologically defined LAs.
Read More
Jordana JampelMelanoma | November 11, 2024
The analysis included the CheckMate trials that involved ICI treatment-naive unresected/metastatic melanoma.
Dr. John Fruehauf, EvolentMelanoma | November 7, 2024
Dr. John Fruehauf, Evolent, talks about a new standard of care in the treatment of stage III melanoma. 
Jordana JampelHead and Neck Cancer | November 7, 2024
The combo's use for conjunctival melanoma demonstrates the combinations high efficacy in treating complex disease.
Rob DillardSkin Cancer | November 7, 2024
A novel method uses tumor-specific profiling to detect antibodies which are unique to early-stage melanoma.
Rob DillardMelanoma | November 7, 2024
The combination therapy of sotiga with pembrolizumab is effective at treating patients with metastatic melanoma.
Rob DillardSkin Cancer | November 7, 2024
Polygenic risk scores may serve as a viable tool to stratify patients based on their risk of invasive melanoma.
Rob DillardMelanoma | November 7, 2024
Several studies have uncovered how immunotherapies work in concert to improve outcomes in patients with melanoma.
Rob DillardSkin Cancer | November 7, 2024
A factor secreted by tumor cells is responsible for the resistance of melanoma to treatment.
Rob DillardASCO 2024 | November 7, 2024
One year of immunotherapy is optimal for treating patients with advanced melanoma.
Rob DillardASCO 2024 | November 7, 2024
Medicaid expansion and improved access to health care services facilitate diagnosing melanoma at an early stage.
Rob DillardMelanoma | November 7, 2024
Risk factors beyond sun exposure, including gene mutations, can influence a person's chances of developing melanoma.
Oncology BrothersOncology Brothers | November 7, 2024
Dr. Patel joins The Oncology Brothers to discuss in-depth how to treat cutaneous melanoma using a treatment algorithm.
Rob DillardADA 2023 | November 7, 2024
DPP-4 inhibitors, used to control blood sugar levels in adults with type 2 diabetes, may reduce the risk of melanoma.
Cailin ConnerSkin Cancer | November 7, 2024
Melanoma is the deadliest of skin cancers. It develops in cells that produce melanin (the pigment that gives skin its ...
Patrick DalySkin Cancer | November 7, 2024
In a recent article, published in the Journal of Cancer Research and Clinical Oncology, researchers examined the protein ...
Patrick DalySkin Cancer | November 7, 2024
According to Shumin Yuan and colleagues from the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer ...
Rob DillardSkin Cancer | November 7, 2024
Patients at high risk of melanoma who undergo routine skin cancer screening and education are more likely to be ...
Kaitlyn D’OnofrioSkin Cancer | November 7, 2024
A study evaluated the feasibility and success of a structured surveillance program at skin clinics to help achieve ...
Rebecca AraujoSkin Cancer | November 7, 2024
Two studies have directly linked mechanisms of aging to melanoma spread and treatment resistance. ...
Advertisement
Advertisement
Advertisement
Latest News

November 20, 2024